Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The invention concerns pharmaceutical preparations containing at least one compound selected from gallic acid, methyl gallate and certain tetragalloylquinic acids as well as methods for isolating them from plant material.
The pharmaceutical preparations are useful for the treatment of inflammatory
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the National Stage of International Application No. PCT/EP2004/005362, filed May 18, 2004.
The present invention relates to novel nutraceutical compositions comprising, as the active ingredients, resveratrol, a derivative, metabolite or
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This application is the U.S. national phase of International Application No. PCT/EP2007/006188, filed 12 Jul. 2007, which designated the U.S. and claims priority to European Application No. 06014645.3, filed 14 Jul. 2006, the entire contents of each of which are hereby incorporated by reference.
The
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
INTRODUCTION
Adequate sleep promotes health and the immune system. Sleep disorders and complaints can occur during childhood, adolescence or adult life [1, 2]. Insufficient sleep affects children's physical health as well as emotional, cognitive and social development. In the youth and adolescent
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
INTRODUCTION
Adequate sleep promotes health and the immune system. Sleep disorders and complaints can occur during childhood, adolescence or adult life [1, 2]. Insufficient sleep affects children's physical health as well as emotional, cognitive and social development. In the youth and adolescent
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This application claims the benefit of U.S. Provisional application Ser. No. 60/946, filed Jul. 1, 1996.
FIELD OF THE INVENTION
The present invention relates generally to a nontoxic extract of Larrea tridentata plant material having therapeutic value and a method of making the same. The present
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates generally to a nontoxic extract of Larrea tridentata plant material having therapeutic value and a method of making the same. The present invention also relates to the field of nontoxic, stable NDGA products used as food additives and therapeutic
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to topical compositions for reducing, preventing, or reversing damage to the eyes resulting from oxidative stress (dry eye, cataracts, retinal degeneration, etc.), and particularly to antioxidant eye drops containing
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
Oral inflammations, such as gingivitis and periodontitis, are common oral conditions. Gingivitis, which is an inflammation of the gums, is the initial stage of gum disease. The direct cause of gingivitis is plaque, which is a soft, sticky, colorless film including
Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse. * Kogu teave põhineb avaldatud teaduslikel uuringutel